The company takes the development of pharmacy chain as the foundation of its business
Dashenlin Pharmaceutical Group Co. is a group enterprise integrating pharmaceutical production and sales. The company takes the development of pharmacy chain as the foundation of its business, and after many years of development, at the end of 2015, there were nearly 2,000 directly operated chain stores and nearly 18,000 employees.
2022 Informatization of China's Rehabilitation Industry
The rehabilitation industry caught the attention of the Chinese government again in 2021, and the industry entered a phase of accelerated development. The rehabilitation industry will first supplement medical resources and continue to explore a rehabilitation model that suits China's actual conditions. Under this context, EqualOcean Intelligence, together with Neusoft Group, released the 2022 Research Report On the Informatization of China's Rehabilitation Industry.
Sep 01, 2022 10:11 AM
ResearchHealthcare, Technology, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchConsumer Discretionary, Healthcare, Real Estate
Tech for Global, Globalization Footprints of the Established and the New
EqualOcean·LinkedIn|Event Preview: Global Business Collaboration and Diverse Team Building
On September 16, EqualOcean and LinkedIn will hold a offline panel on the theme of "Global Business Collaboration and Diverse Team Building", and enterprises dedicated to foreign trade and global business or those who have related plans are welcomed to register.
Sep 14, 2022 05:34 PM
China to Implement Strict Regulatory Environment for Online Drug Sales
The State Administration for Market Regulation (SAMR) recently promulgated《Measures for the Supervision and Administration of Online Drug Sales》(Order of the State Administration for Market Regulation No. 58), which will take effect as of 1 December 2022.
Sep 02, 2022 04:56 PM
15 Companies to Watch in August 2022- Healthcare
Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China’s healthcare space in August 2022. And the following is a list of deals that we have selected for you, based on a number of criteria including the funding amount, the financial backers, and the segments in which the startups operate.
Sep 02, 2022 10:20 AM
Analysis of In Vitro Diagnostics Industry in China
It has been almost three years since the coronavirus outbreak. In the post-Covid era, PCR tests and antigen reagents have become part of daily essentials. The increasing demand for PCR tests drives the development of IVD in China. What is IVD? How to explain its popularity in China over the past two or three years? You will find all the answers above in this article.
Aug 23, 2022 12:15 PM